1FM6, 1FM9, 1I7I, 1K74, 1KNU, 1NYX, 1PRG, 1RDT, 1WM0, 1ZEO, 1ZGY, 2ATH, 2F4B, 2FVJ, 2G0G, 2G0H, 2GTK, 2HFP, 2HWQ, 2HWR, 2I4J, 2I4P, 2I4Z, 2OM9, 2P4Y, 2POB, 2PRG, 2Q59, 2Q5P, 2Q5S, 2Q61, 2Q6R, 2Q6S, 2Q8S, 2QMV, 2VSR, 2VST, 2VV0, 2VV1, 2VV2, 2VV3, 2VV4, 2XKW, 2YFE, 2ZK0, 2ZK1, 2ZK2, 2ZK3, 2ZK4, 2ZK5, 2ZK6, 2ZNO, 2ZVT, 3ADS, 3ADT, 3ADU, 3ADV, 3ADW, 3ADX, 3AN3, 3AN4, 3B0Q, 3B0R, 3B1M, 3B3K, 3BC5, 3CDP, 3CDS, 3CS8, 3CWD, 3D6D, 3DZU, 3DZY, 3E00, 3ET0, 3ET3, 3FEJ, 3FUR, 3G9E, 3GBK, 3H0A, 3HO0, 3HOD, 3IA6, 3K8S, 3KMG, 3LMP, 3NOA, 3OSI, 3OSW, 3PBA, 3PO9, 3PRG, 3QT0, 3R5N, 3R8A, 3R8I, 3S9S, 3SZ1, 3T03, 3TY0, 3U9Q, 3V9T, 3V9V, 3V9Y, 3VJH, 3VJI, 3VN2, 3VSO, 3VSP, 4A4V, 4A4W, 4E4K, 4E4Q, 4EM9, 4EMA, 4F9M, 4FGY, 4PRG
· DNA binding
· chromatin binding
· sequence-specific DNA binding transcription factor activity
· steroid hormone receptor activity
· ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity
· prostaglandin receptor activity
· protein binding
· drug binding
· zinc ion binding
· enzyme binding
· ligand-dependent nuclear receptor transcription coactivator activity
· activating transcription factor binding
· sequence-specific DNA binding
· transcription regulatory region DNA binding
· retinoid X receptor binding
· nucleoplasm
· placenta development
· negative regulation of acute inflammatory response
· transcription initiation from RNA polymerase II promoter
· lipid metabolic process
· induction of apoptosis
· activation of cysteine-type endopeptidase activity involved in apoptotic process
· signal transduction
· heart development
· response to nutrient
· regulation of blood pressure
· response to cold
· gene expression
· negative regulation of macrophage derived foam cell differentiation
· negative regulation of receptor biosynthetic process
· negative regulation of cholesterol storage
· negative regulation of sequestering of triglyceride
· long-chain fatty acid transport
· fatty acid oxidation
· monocyte differentiation
· negative regulation of cell growth
· epithelial cell differentiation
· response to caffeine
· organ regeneration
· response to retinoic acid
· cellular response to insulin stimulus
· response to vitamin A
· response to lipid
· peroxisome proliferator activated receptor signaling pathway
· response to drug
· glucose homeostasis
· lipoprotein transport
· response to estrogen stimulus
· innate immune response
· cell fate commitment
· positive regulation of fat cell differentiation
· low-density lipoprotein particle receptor biosynthetic process
· negative regulation of transcription, DNA-dependent
· positive regulation of transcription, DNA-dependent
· positive regulation of transcription from RNA polymerase II promoter
· positive regulation of fatty acid oxidation
· cell maturation
· negative regulation of smooth muscle cell proliferation
· positive regulation of oligodendrocyte differentiation
· white fat cell differentiation
· brown fat cell differentiation
· positive regulation of sequence-specific DNA binding transcription factor activity
· negative regulation of telomerase activity
· lipid homeostasis
· response to low-density lipoprotein particle stimulus
· negative regulation of interferon-gamma-mediated signaling pathway
· regulation of cholesterol transporter activity
过氧化物酶体增殖物活化受体γ（Peroxisome proliferator-activated receptor gamma ，缩写为PPAR-γ或PPARG），也称胰岛素增敏剂受体（glitazone receptor），或 NR1C3（意为核受体第一亚科C集团第3号，nuclear receptor subfamily 1, group C, member 3）是一种位于人类染色体上的二型核受体，由PPARG基因编码。对脂肪细胞和胰岛素有重要的作用，是治疗糖尿病的研究对象之一。
